October 5, 2023 02:58 PM EDT

HHS announces move to commercial distribution for Merck's antiviral Lagevrio

Katherine Lewin

News Reporter

The US Department of Health and Human Services announced that Merck’s Covid-19 antiviral Lagevrio will be transitioned from government-managed distribution to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

HHS announces move to commercial distribution for Merck's antiviral Lagevrio

Katherine Lewin

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Updated: Novartis claims best earnings in years, validating shift to pure-play strategy

Roche separates CFO, informatics posts; Lilly execs land at Kailera, Neurocrine

Vertex's non-opioid pain drug is approved by FDA, bringing first of new class to market

Friday IPO doubleheader from Maze and Metsera brings life to biotech debuts

Daiichi Sankyo taps new CEO, aims to build up ADC franchise

Why the premier recruitment agency in the world is giving up recruiting, and sponsors should, too

HHS an­nounces move to com­mer­cial dis­tri­b­u­tion for Mer­ck­'s an­tivi­ral Lagevrio

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

HHS announces move to commercial distribution for Merck's antiviral Lagevrio